Canada markets open in 1 hour 40 minutes

Matinas BioPharma Holdings, Inc. (MTNB)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.1500-0.0092 (-5.78%)
At close: 04:00PM EDT
0.1545 +0.00 (+3.00%)
Pre-Market: 07:26AM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 37.62M
Enterprise Value 32.91M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.58
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.64
52-Week Change 3-58.33%
S&P500 52-Week Change 325.22%
52 Week High 30.8900
52 Week Low 30.1100
50-Day Moving Average 30.1746
200-Day Moving Average 30.2099

Share Statistics

Avg Vol (3 month) 31.62M
Avg Vol (10 day) 3632.21k
Shares Outstanding 5250.82M
Implied Shares Outstanding 6250.82M
Float 8244.45M
% Held by Insiders 12.53%
% Held by Institutions 110.47%
Shares Short (May 15, 2024) 42.36M
Short Ratio (May 15, 2024) 42.13
Short % of Float (May 15, 2024) 40.96%
Short % of Shares Outstanding (May 15, 2024) 40.94%
Shares Short (prior month Apr 15, 2024) 43.19M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-52.02%
Return on Equity (ttm)-98.57%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -23.69M
Net Income Avi to Common (ttm)-23.25M
Diluted EPS (ttm)-0.1100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.11M
Total Cash Per Share (mrq)0.03
Total Debt (mrq)3.4M
Total Debt/Equity (mrq)23.35%
Current Ratio (mrq)5.15
Book Value Per Share (mrq)0.07

Cash Flow Statement

Operating Cash Flow (ttm)-16.96M
Levered Free Cash Flow (ttm)-8.39M